Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Metastatic Colorectal Cancer
Clinical trial register · United States · industry-sponsored

Metastatic Colorectal Cancer Trials in the USA, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9128 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 04 Nov 2026, 03:16 UTC
9128
Studies in scope
industry-sponsored, all four open statuses
4968
Recruiting now
open to new participants
2189
Lead sponsors
across recruiting studies
Top states
California 10 Florida 9 Arizona 7 Illinois 7 Colorado 6
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Metastatic Colorectal Cancer trials in the USA

15 of 9128 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
Hoffmann-La Roche
Phase 1
180
Illinois, Missouri, Nebraska, Texas, Wisconsin
2026-10-13
Recruiting
EMD Serono Research & Development Institute, Inc.
Phase 3
1,020
Colorado, Florida, Illinois, Michigan, Minnesota, Missouri, New York, Tennessee
2026-05-06
Active, closed
AstraZeneca
Phase 2
82
Arizona, California, District of Columbia, Maryland, Massachusetts, Minnesota, New Jersey, New York
2025-03-12
Recruiting
Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer
NCT06824064Metastatic Colorectal Cancer, Advanced Colorectal Cancer
Riboscience, LLC.
Phase 2
150
Delaware, Texas
2025-01-17
Active, closed
AbbVie
Phase 2
74
California, Colorado, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana
2024-11-08
Recruiting
Amgen
Phase 3
450
Arizona, California, Connecticut, Florida, Georgia, Illinois, Kentucky, Michigan
2024-07-17
Active, closed
Cardiff Oncology
Phase 2
110
Arizona, Arkansas, California, Florida, Hawaii, Indiana, Kansas, Michigan
2024-02-27
Active, closed
Agenus Inc.
Phase 2
234
Arizona, California, Colorado, Delaware, Florida, Massachusetts, Michigan, New Jersey
2022-11-30
Active, closed
Akeso
Phase 2
254
California, Virginia
2022-06-27
Recruiting
Hoffmann-La Roche
Phase 1
542
Alabama, Arizona, California, Colorado, Connecticut, Florida, Illinois, Louisiana
2021-10-22
Active, closed
Mirati Therapeutics Inc.
Phase 3
461
Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia
2021-06-24
Active, closed
Bristol-Myers Squibb
Phase 3
839
California, Colorado, Illinois, New York, Oregon, Pennsylvania, Texas, Virginia
2019-08-05
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 5 November 2026. https://priyalifescience.com/clinical-trials-usa/condition/metastatic-colorectal-cancer

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,128 studies in total at the last sync on 04 Nov 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies listing the condition Metastatic Colorectal Cancer.

How many Metastatic Colorectal Cancer trials are recruiting in the US?

7 of the 15 studies on this page are recruiting new participants as of the 04 Nov 2026, 03:16 UTC sync. A further 0 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Metastatic Colorectal Cancer), 15 studies
PhaseStudiesRecruitingShare
Phase 28253.3%
Phase 34226.7%
Phase 12213.3%
Phase 1/2116.7%

Most active sponsors

Lead sponsors with the most studies (Metastatic Colorectal Cancer)
Lead sponsorStudiesRecruiting
AbbVie21
Hoffmann-La Roche22
Agenus Inc.10
Akeso10
Amgen11
AstraZeneca10
BioNTech SE11
Bristol-Myers Squibb10
Cardiff Oncology10
EMD Serono Research & Development Institute, Inc.11

Top states

Top states (Metastatic Colorectal Cancer), by number of studies with a site there
StateStudies
California10
Florida9
Arizona7
Illinois7
Colorado6
Connecticut6
Michigan6
Texas5
Georgia4
Massachusetts3
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.